Boston Scientific Corporation: clinical-trial pipeline

Boston Scientific Corporation is the sponsor of 537 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 71 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials71
Phase 2/3 and 357
Countries51
New in 90 days2

Trials by phase

PhaseTrials
Not applicable409
Phase 343
Phase 440
Phase 2/314
Phase 213
Phase 19
Phase 1/26
Early phase 12
Not stated1

Trials by status

StatusTrials
Completed386
Terminated58
Recruiting33
Active, not recruiting31
Withdrawn or not authorised19
Not yet recruiting7
Suspended or halted2
Unknown1

Condition areas

AreaTrials
Cardiovascular279
Oncology52
Neurology39
Gastroenterology and liver35
Respiratory34
Nephrology and urology29
Musculoskeletal25
Rare and genetic diseases20
Metabolic and endocrine (diabetes, obesity)9
Haematology5
Immunology and rheumatology2
Women's health and obstetrics1

Countries

CountryTrials
United States288
Germany128
France101
United Kingdom91
Italy88
Netherlands83
Belgium79
Spain77
Canada65
Australia58
China47
Austria41
Japan40
Switzerland32
Denmark32

Latest changes

DayChangeTrial
2026-10-09New trial postedAn Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Devic…
2026-09-15New trial postedA Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation Syst…

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT04655248ACURATE neo2™ Post Market Clinical Follow up StudyNot applicableActive, not recruitingSwitzerland, Germany, Denmark, Spain +4
NCT04674969Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral VasculatureNot applicableRecruitingAustria, Australia, Canada, China +8
NCT01385176Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)Not applicableActive, not recruitingBelgium, Czechia, Germany, Spain +4
NCT07458217Combined CM and STN Stimulation for Motor EpilepsyNot applicableNot yet recruiting
NCT06808217A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation…Not applicableActive, not recruitingAustria, Switzerland, Germany, Spain +6
NCT06656884FARAPULSE Workflow Assessment RegistryNot applicableActive, not recruitingAustria, Belgium, Germany, Spain +6
NCT07458243A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chine…Not applicableNot yet recruiting
NCT04798768Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycard…Not applicableActive, not recruitingAustria, Canada, Czechia, Spain +5
NCT07711093Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal SurgeryNot applicableNot yet recruitingUnited States
NCT07062094Safety and Effectiveness of Orbera365™ Intragastric Balloon SystemNot applicableRecruitingCzechia, Spain, United Kingdom
NCT05303467A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recu…Phase 1RecruitingUnited States
NCT06510556Feasibility Study of the FARAFLEX Mapping and PFA SystemNot applicableRecruitingBelgium, Czechia, Croatia, Italy
NCT04647253A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects Wi…Phase 3Active, not recruitingUnited States
NCT07820930A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrograph…Not applicableNot yet recruiting
NCT07444320Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA SystemNot applicableRecruitingCzechia, Hong Kong SAR China, Croatia, Taiwan
NCT06492174A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects Wi…Phase 3Active, not recruitingUnited States
NCT04192591A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)Not applicableActive, not recruitingUnited States
NCT06451614SpaceIT Hydrogel System for Perirectal SpacingNot applicableActive, not recruitingCanada, United States
NCT06819865A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary EmbolismNot applicableRecruitingChina
NCT07867886An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With R…Not applicableNot yet recruitingGermany, Spain, France, Netherlands
NCT03664609Deep Brain Stimulation (DBS) Retrospective Outcomes StudyNot applicableRecruitingBelgium, Germany, Spain, France +2
NCT07190807Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current ControlNot applicableRecruitingUnited States
NCT07015424Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassNot applicableRecruitingUnited States
NCT06982235Stone and Laser Therapies Post-Market Study (SALT)Not applicableActive, not recruitingUnited States
NCT04394546CHAMPION-AF Clinical TrialNot applicableActive, not recruitingAustralia, Belgium, Canada, Switzerland +12

Website: bostonscientific.com. All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "Boston Scientific Corporation clinical trials: 71 open, 57 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/bostonscientific-com/, data as of 2026-10-25.